{"id":"https://openalex.org/W4361945495","doi":"https://doi.org/10.1158/1078-0432.c.6524306","title":"Data from Contribution of Beta-HPV Infection and UV Damage to Rapid-Onset Cutaneous Squamous Cell Carcinoma during BRAF-Inhibition Therapy","display_name":"Data from Contribution of Beta-HPV Infection and UV Damage to Rapid-Onset Cutaneous Squamous Cell Carcinoma during BRAF-Inhibition Therapy","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361945495","doi":"https://doi.org/10.1158/1078-0432.c.6524306"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.6524306","doi":"https://doi.org/10.1158/1078-0432.c.6524306","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6524306","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.c.6524306","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059183616","display_name":"Daniel N. Cohen","orcid":"https://orcid.org/0000-0003-2561-2495","observed_orcids":["https://orcid.org/0000-0003-2561-2495"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel N. Cohen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085496877","display_name":"Steven K. Lawson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steven K. Lawson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019724193","display_name":"Aaron C. Shaver","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aaron C. Shaver","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100569786","display_name":"Liping Du","orcid":"https://orcid.org/0000-0001-5168-1756","observed_orcids":["https://orcid.org/0000-0001-5168-1756"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Liping Du","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111988363","display_name":"Harrison P. Nguyen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Harrison P. Nguyen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081065929","display_name":"Qin He","orcid":"https://orcid.org/0000-0002-9887-9388","observed_orcids":["https://orcid.org/0000-0002-9887-9388"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qin He","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025067315","display_name":"Douglas Buckner Johnson","orcid":"https://orcid.org/0000-0002-6390-773X","observed_orcids":["https://orcid.org/0000-0002-6390-773X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Douglas B. Johnson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059206654","display_name":"Wilfred A. Lumbang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wilfred A. Lumbang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114137031","display_name":"Brent R. Moody","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brent R. Moody","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085824379","display_name":"James L. Prescott","orcid":"https://orcid.org/0009-0003-5415-737X","observed_orcids":["https://orcid.org/0009-0003-5415-737X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James L. Prescott","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009046067","display_name":"Pranil Chandra","orcid":"https://orcid.org/0009-0002-1313-3681","observed_orcids":["https://orcid.org/0009-0002-1313-3681"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pranil K. Chandra","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103180829","display_name":"Alan S. Boyd","orcid":"https://orcid.org/0000-0002-4635-5320","observed_orcids":["https://orcid.org/0000-0002-4635-5320"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alan S. Boyd","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063646457","display_name":"Jeffrey P. Zwerner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey P. Zwerner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049037123","display_name":"Jason B. Robbins","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jason B. Robbins","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000478173","display_name":"Stephen Keith Tyring","orcid":"https://orcid.org/0000-0002-3337-0580","observed_orcids":["https://orcid.org/0000-0002-3337-0580"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen K. Tyring","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112247130","display_name":"Peter L. Rady","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter L. Rady","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088431604","display_name":"James D. Chappell","orcid":"https://orcid.org/0000-0002-7382-7864","observed_orcids":["https://orcid.org/0000-0002-7382-7864"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James D. Chappell","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062656698","display_name":"Yu Shyr","orcid":"https://orcid.org/0000-0003-2086-9670","observed_orcids":["https://orcid.org/0000-0003-2086-9670"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yu Shyr","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103514741","display_name":"Jeffrey R. Infante","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey R. Infante","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5075566772","display_name":"Jeffrey Alan Sosman","orcid":"https://orcid.org/0000-0002-0650-9698","observed_orcids":["https://orcid.org/0000-0002-0650-9698"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey A. Sosman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11306","display_name":"Nonmelanoma Skin Cancer Studies","score":0.9785000085830688,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11306","display_name":"Nonmelanoma Skin Cancer Studies","score":0.9785000085830688,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.005200000014156103,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cutaneous-squamous-cell-carcinoma","display_name":"cutaneous squamous cell carcinoma","score":0.8930000066757202},{"id":"https://openalex.org/keywords/braf-inhibition","display_name":"BRAF inhibition","score":0.7350000143051147},{"id":"https://openalex.org/keywords/vemurafenib","display_name":"vemurafenib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/dabrafenib","display_name":"dabrafenib","score":1.0},{"id":"https://openalex.org/keywords/advanced-melanoma","display_name":"advanced melanoma","score":0.7419999837875366},{"id":"https://openalex.org/keywords/ultraviolet-radiation","display_name":"ultraviolet radiation","score":0.7590000033378601},{"id":"https://openalex.org/keywords/ras-mutations","display_name":"RAS mutations","score":0.6909999847412109},{"id":"https://openalex.org/keywords/alk-mutations","display_name":"ALK mutations","score":0.9190000295639038}],"concepts":[{"id":"https://openalex.org/C2776131300","wikidata":"https://www.wikidata.org/wiki/Q423111","display_name":"Vemurafenib","level":4,"score":0.6597678661346436},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6084320545196533},{"id":"https://openalex.org/C2778830669","wikidata":"https://www.wikidata.org/wiki/Q3011604","display_name":"Dabrafenib","level":5,"score":0.5844006538391113},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5590768456459045},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.47991713881492615},{"id":"https://openalex.org/C555283112","wikidata":"https://www.wikidata.org/wiki/Q1637543","display_name":"Carcinogenesis","level":3,"score":0.47557345032691956},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.42447441816329956},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3610221743583679},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34638822078704834},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.c.6524306","doi":"https://doi.org/10.1158/1078-0432.c.6524306","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6524306","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.6524306","doi":"https://doi.org/10.1158/1078-0432.c.6524306","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6524306","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2083251207","https://openalex.org/W2886361148","https://openalex.org/W2519716151","https://openalex.org/W2146161846","https://openalex.org/W2580919377","https://openalex.org/W4232648724","https://openalex.org/W1768812886","https://openalex.org/W2066500792","https://openalex.org/W2053865990","https://openalex.org/W2030099076"],"abstract_inverted_index":{"Abstract":[0],"Purpose:":[1],"BRAF-inhibition":[2],"(BRAFi)":[3],"therapy":[4],"for":[5,40,79,98,141],"advanced":[6],"melanoma":[7],"carries":[8],"a":[9,37],"high":[10],"rate":[11],"of":[12,21,82,125,173,223,231,248,251],"secondary":[13],"cutaneous":[14,83],"squamous":[15],"cell":[16],"carcinoma":[17],"(cSCC)":[18],"and":[19,26,55,86,101,143,161,183,194,206,211,214],"risk":[20],"other":[22],"cancers.":[23],"UV":[24,99,144,209],"radiation":[25],"\u03b1-genus":[27],"human":[28],"papillomavirus":[29],"(HPV)":[30],"are":[31],"highly":[32],"associated":[33],"with":[34,53,109,179,234],"SCC,":[35],"but":[36],"novel":[38,162,212],"role":[39],"\u03b2-genus":[41,153],"HPV":[42],"is":[43],"suspected":[44],"in":[45,51,58,107,123,197,253],"BRAFi-cSCC.":[46,59],"Cutaneous":[47],"\u03b2-HPV":[48,163,218],"may":[49],"act":[50],"concert":[52],"host":[54,87],"environmental":[56],"factors":[57,232],"Experimental":[60],"Design:":[61],"Primary":[62],"BRAFi-cSCC":[63,116,118,198],"tissue":[64],"DNA":[65],"isolated":[66],"from":[67,73],"patients":[68,113],"receiving":[69],"vemurafenib":[70,128],"or":[71],"dabrafenib":[72],"two":[74],"cancer":[75,252],"centers":[76],"was":[77],"analyzed":[78,106],"the":[80,221,245],"presence":[81],"oncogenic":[84],"viruses":[85],"genetic":[88,195],"mutations.":[89,216],"Diagnostic":[90],"specimens":[91],"underwent":[92],"consensus":[93],"dermatopathology":[94],"review.":[95],"Clinical":[96],"parameters":[97,196],"exposure":[100,145],"disease":[102],"course":[103],"were":[104,157,165],"statistically":[105],"conjunction":[108],"histopathology.":[110],"Results:":[111],"Twenty-nine":[112],"contributed":[114],"69":[115],"lesions.":[117],"had":[119],"wart-like":[120,202],"features":[121],"(BRAFi-cSCC-WF)":[122],"22%":[124],"specimens.":[126],"During":[127],"therapy,":[129],"BRAFi-cSCC-WF":[130],"arose":[131],"11.6":[132],"weeks":[133],"more":[134],"rapidly":[135],"than":[136],"conventional":[137],"cSCC":[138],"when":[139],"controlled":[140],"gender":[142],"(P":[146],"value":[147],"=":[148],"0.03).":[149],"Among":[150],"all":[151],"BRAFi-cSCC,":[152],"HPV-17,":[154],"HPV-38,":[155,205],"HPV-111":[156,207],"most":[158],"frequently":[159],"isolated,":[160],"genotypes":[164,219],"discovered":[166],"(CTR,":[167],"CRT-11,":[168],"CRT-22).":[169],"Sequencing":[170],"revealed":[171],"63%":[172],"evaluated":[174],"BRAFi-cSCCs":[175],"harbored":[176],"RAS":[177],"mutations":[178,185],"PIK3CA,":[180],"CKIT,":[181],"ALK,":[182],"EGFR":[184],"also":[186],"detected.":[187],"Conclusions:":[188],"We":[189],"examined":[190],"clinical,":[191],"histopathologic,":[192],"viral,":[193],"demonstrating":[199],"rapid":[200],"onset;":[201],"histomorphology;":[203],"\u03b2-HPV-17,":[204],"infection;":[208],"damage;":[210],"ALK":[213],"CKIT":[215],"Discovered":[217],"expand":[220],"spectrum":[222],"tumor-associated":[224],"viruses.":[225],"These":[226],"findings":[227],"enhance":[228],"our":[229],"understanding":[230],"cooperating":[233],"BRAF":[235],"inhibition":[236],"that":[237],"accelerate":[238],"keratinocyte":[239],"oncogenesis":[240],"as":[241,243],"well":[242],"broaden":[244],"knowledge":[246],"base":[247],"multifactorial":[249],"mediators":[250],"general.":[254],"Clin":[255],"Cancer":[256],"Res;":[257],"21(11);":[258],"2624\u201334.":[259],"\u00a92015":[260],"AACR.":[261]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2023-04-05T00:00:00"}